Bio-Rad Laboratories, Inc. (BIO.B)

Bio-Rad Laboratories Statistics

Total Valuation

BIO.B has a market cap or net worth of $8.33 billion.

Market Cap	8.33B
Enterprise Value	n/a

Important Dates

The next confirmed earnings date is Thursday, August 1, 2024, after market close.

Earnings Date	Aug 1, 2024
Ex-Dividend Date	n/a

Share Statistics

BIO.B has 28.23 million shares outstanding.

Shares Outstanding	28.23M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	97.88%
Owned by Institutions (%)	0.08%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	30.40
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	1.21

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	8,030
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -24.08% in the last 52 weeks. The beta is 0.93, so BIO.B's price volatility has been similar to the market average.

Beta (5Y)	0.93
52-Week Price Change	-24.08%
50-Day Moving Average	283.25
200-Day Moving Average	308.52
Relative Strength Index (RSI)	89.07
Average Volume (20 Days)	28

Short Selling Information

The latest short interest is 117, so 0.00% of the outstanding shares have been sold short.

Short Interest	117
Short Previous Month	118
Short % of Shares Out	0.00%
Short % of Float	n/a
Short Ratio (days to cover)	1.08

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	n/a
Pretax Income	n/a
Net Income	n/a
EBITDA	n/a
EBIT	n/a
Earnings Per Share (EPS)	-$10.68

Balance Sheet

Cash & Cash Equivalents	n/a
Total Debt	n/a
Net Cash	n/a
Net Cash Per Share	n/a
Equity (Book Value)	n/a
Book Value Per Share	n/a
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BIO.B does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	n/a
FCF Yield	n/a

Analyst Forecast

The average price target for BIO.B is $410.00, which is 39.35% higher than the current price. The consensus rating is "Buy".

Price Target	$410.00
Price Target Difference	39.35%
Analyst Consensus	Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on March 8, 2002. It was a forward split with a ratio of 2:1.

Last Split Date	Mar 8, 2002
Split Type	Forward
Split Ratio	2:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a